You have 9 free searches left this month | for more free features.

Drug withdrawal symptoms

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug Withdrawal Symptoms, Critical Care, Child Trial in Oslo (Algorithm for tapering og analgosedation)

Completed
  • Drug Withdrawal Symptoms
  • +2 more
  • Algorithm for tapering og analgosedation
  • Oslo, Norway
    Oslo University Hospital, Rikshospitalet
Apr 19, 2022

Nicotine Dependence Trial in Baltimore (Transcranial Direct Current Stimulation, Sham)

Suspended
  • Nicotine Dependence
  • Transcranial Direct Current Stimulation
  • sham
  • Baltimore, Maryland
    National Institute on Drug Abuse
Jan 4, 2023

Kratom Product Effects Among Regular Consumers

Not yet recruiting
  • Withdrawal Symptoms
  • Effects from acute kratom exposure
  • (no location specified)
Oct 20, 2023

Chronic Pain, Drug Dependence of Morphine Type, Symptom, Withdrawal Trial (Probenecid)

Not yet recruiting
  • Chronic Pain
  • +2 more
  • (no location specified)
May 20, 2022

Withdrawal Symptoms, Opioid Use Disorder, Opioid Use Trial in Atlanta (Transcutaneous Cervical Vagal Nerve Stimulation, Sham

Not yet recruiting
  • Withdrawal Symptoms
  • +2 more
  • Transcutaneous Cervical Vagal Nerve Stimulation
  • +2 more
  • Atlanta, Georgia
  • +6 more
Apr 14, 2023

Tobacco Dependence, Withdrawal Symptoms, Smoking Cessation Trial in Phoenix, Burbank (1.0mg Varenicline b.i.d., 0.5mg

Completed
  • Tobacco Dependence
  • +2 more
  • 1.0mg Varenicline b.i.d.
  • +2 more
  • Phoenix, Arizona
  • +1 more
Apr 29, 2022

E-cigarette Use, Withdrawal Trial in Baltimore (Transdermal Nicotine Patch, Placebo Nicotine Patch)

Not yet recruiting
  • E-cigarette Use
  • Withdrawal
  • Transdermal Nicotine Patch
  • Placebo Nicotine Patch
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit
Sep 28, 2023

Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • BXCL501 (180 micrograms)
  • +3 more
  • (no location specified)
Jan 24, 2023

Alcohol Withdrawal Trial in Copenhagen (Blood samples)

Recruiting
  • Alcohol Withdrawal
  • Blood samples
  • Copenhagen, Denmark
    Bispebjerg and Frederiksberg Hospital
Sep 28, 2022

Opiate Withdrawal Syndrome Trial in Zagazig (Venlafaxine, Lofexidine)

Completed
  • Opiate Withdrawal Syndrome
  • Zagazig, Sharkia, Egypt
    Faculty of medicine
Oct 5, 2022

Opioid Use Disorder Trial in Wernersville (Bridge™ active device, Bridge™ sham device)

Enrolling by invitation
  • Opioid Use Disorder
  • Bridge™ active device
  • Bridge™ sham device
  • Wernersville, Pennsylvania
    Caron Treatment Centers
Jun 21, 2023

Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)

Not yet recruiting
  • Opioid Withdrawal (Disorder)
  • Standard of Care with Lofexidine
  • Standard of Care without Lofexidine
  • (no location specified)
Sep 14, 2023

Cannabis Withdrawal Trial (PP-01 High Dose, PP-01 Low Dose, Placebo)

Not yet recruiting
  • Cannabis Withdrawal
  • PP-01 High Dose
  • +4 more
  • (no location specified)
Aug 9, 2022

Opioid-Use Disorder Trial in Baltimore (Placebo, TRV734)

Recruiting
  • Opioid-Use Disorder
  • Baltimore, Maryland
    National Institute on Drug Abuse
Dec 14, 2022

Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe, Withdrawal Symptoms Trial in Washington, Rockville (CBOT + TAU, Sham

Recruiting
  • Opioid Use Disorder, Moderate
  • +4 more
  • CBOT + TAU
  • Sham + TAU
  • Washington, District of Columbia
  • +3 more
Jul 30, 2021

Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome Trial in Hershey (microRNA-146a level, microRNA-192 level,

Recruiting
  • Neonatal Opioid Withdrawal Syndrome
  • Neonatal Abstinence Syndrome
  • microRNA-146a level
  • +2 more
  • Hershey, Pennsylvania
    Penn State Milton S. Hershey Medical Center
Jun 30, 2023

Food Addiction Trial in Ann Arbor (Dietary change (low ultra-processed food), Dietary change (high ultra-processed food))

Recruiting
  • Food Addiction
  • Dietary change (low ultra-processed food)
  • Dietary change (high ultra-processed food)
  • Ann Arbor, Michigan
    University of Michigan
Sep 12, 2023

Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) Trial in Buffalo (Acute (24-hour) abstinence, Ad libitum smoking/vaping)

Recruiting
  • Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
  • Acute (24-hour) abstinence
  • Ad libitum smoking/vaping
  • Buffalo, New York
    University at Buffalo
Mar 6, 2023

Smoking Cessation, Withdrawal Symptoms Trial in Hualien City (Honey, Water)

Recruiting
  • Smoking Cessation
  • Withdrawal Symptoms
  • Honey
  • Water
  • Hualien City, Taiwan
    Hualien Tzu Chi Hospital
Mar 2, 2022

Graves Disease, Relapse, Treatment Trial in Nanjing (Methimazole)

Recruiting
  • Graves Disease
  • +3 more
  • Nanjing, China
    the First Affiliated Hospital of Nanjing Medical University
Jul 21, 2022

Gambling Trial in Incheon (group counseling, auricular acupressure, acupressure)

Recruiting
  • Gambling
  • group counseling
  • +2 more
  • Incheon, Korea, Republic of
    Inha University Hospital
Feb 6, 2022

T-bet B Cells in Persistent Virus Control After Discontinuance

Completed
  • Chronic HBV Infection
  • Drug Withdrawal
  • T-bet B cell
  • Shanghai, China
    Changhai hospital
Sep 1, 2023

Alcohol Withdrawal Trial in New Haven (Prazosin, 12-Step Facilitation with Relapse Prevention and Contingency Management)

Recruiting
  • Alcohol Withdrawal
  • Prazosin
  • 12-Step Facilitation with Relapse Prevention and Contingency Management
  • New Haven, Connecticut
  • +1 more
Jan 13, 2022

Opioid Withdrawal, Opioid Use Disorder, Opioid Craving Trial in Baltimore (Morphine, Naloxone + lofexidine pretreatment,

Recruiting
  • Opioid Withdrawal
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University Bayview Medical Campus
Feb 18, 2022

Cardiomyopathy, Dilated Trial (Patients with cardiac function recovered for more than one year and discontinued were in the

Not yet recruiting
  • Cardiomyopathy, Dilated
  • Patients with cardiac function recovered for more than one year and discontinued were in the discontinuation group.
  • (no location specified)
Sep 8, 2023